Chronic Kidney Disease and COVID-19: Outcomes of Hospitalized Patients from a Tertiary Care Centre, Dhaka, Bangladesh

: Introduction: COVID-19 is currently a global health issue and an important cause of mortality. Chronic kidney disease (CKD) is one of the risk factors for infection, morbidity and mortality by SARS-CoV-2. In our study, we aimed to evaluate the clinical presentation and outcomes of CKD patients with COVID-19 and identify predictors of mortality. Aim of the study: Aim of the study was to find out the Outcome of patients with Chronic Kidney Disease during COVID-19. Methods: This retrospective study was conducted at the department of Medicine in Shaheed Monsur Ali Medical College, Dhaka, Bangladesh. This study was carried out from January 2020 to December 2021 with 115 patients. Results: This is a retrospective observational; 115 patients were enrolled and analyzed in this study. The age distribution of the participants; most of the 38(33.04%) patients were from the age range 60≥ years, and the lowest 3(2.61%) patients were from the age range ≤18 years. The figure shows the sex distribution of the study; the male patients were 61.74%, and the females were 38.26%. From our study, there were 52(45.22%) patients turned RTPCR negative within 54 days, 40(34.78%) patients needed 36 days, and 23(20.00%) patients needed 18 days to get negative results. Figure 2 shows the study's outcome; the survivor's rate was 78.26%, and the mortality rate was 21.74%. Conclusion: On-admission kidney dysfunction was associated with disease severity and poor short-term prognosis in patients with COVID-19. Thus, on-admission kidney dysfunction has the potential to stratify risks in COVID-19 patients.